Skip to main content
. Author manuscript; available in PMC: 2013 Mar 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2011 Jul 19;82(4):1367–1375. doi: 10.1016/j.ijrobp.2011.05.027

Table 4.

Number of Patients with Grade 3–4 Adverse Event occurring Prior to Surgery by Category, Term, and Grade Definitely, Probably, or Possibly Related to Protocol Treatment

Category
Term
Capecitabine/Irinotecan/RT
(n=52)
Grade
Capecitabine/Oxaliplatin/RT
(n=52)
Grade

1 2 3 4 1 2 3 4
BLOOD/BONE MARROW 13 14 5 0 18 11 2 0
  Hemoglobin 18 3 0 0 13 4 1 0
  Leukopenia NOS 13 11 4 0 9 3 2 0
  Lymphopenia 1 0 1 0 0 2 0 0
  Neutrophil count 10 4 3 0 2 3 1 0
CONSTITUTIONAL SYMPTOMS 26 7 1 0 17 12 4 0
  Fatigue 20 7 1 0 17 10 4 0
DERMATOLOGY/SKIN 11 10 1 0 12 15 0 0
  Dermatitis radiation NOS 4 7 1 0 5 4 0 0
GASTROINTESTINAL 17 21 6 0 18 20 9 1
  Anorexia 7 2 1 0 1 7 1 0
  Colitis NOS 0 0 0 0 0 1 2 0
  Dehydration 0 2 1 0 0 3 4 0
  Diarrhea NOS 17 14 4 0 18 14 9 0
  Dry mouth 2 0 0 0 1 0 1 0
  Enteritis 0 0 1 0 0 1 0 1
  Nausea 14 6 0 0 16 8 1 0
  Proctitis NOS 4 1 0 0 6 6 1 0
  Small intestinal stricture NOS 0 0 1 0 0 0 0 0
  Tooth development disorder 0 0 0 0 0 0 1 0
  Vomiting NOS 2 4 0 0 4 4 1 0
INFECTION 0 1 0 0 0 1 2 0
  Febrile neutropenia 0 0 0 0 0 0 1 0
  Infection with Grade 3 or 4 neutrophils (ANC <1.0 × 10e9/L): Urinary tract NOS 0 0 0 0 0 1 1 0
METABOLIC/LABORATORY 14 6 3 0 12 7 4 1
  Aspartate aminotransferase increased 3 0 1 0 6 2 0 0
  Hyperglycemia NOS 6 2 1 0 4 1 0 0
  Hypoalbuminemia 5 2 0 0 2 3 2 0
  Hypocalcemia 4 0 0 0 4 2 1 0
  Hypokalemia 7 0 0 0 6 0 1 1
  Hyponatremia 4 0 1 0 4 0 2 0
NEUROLOGY 2 3 0 0 13 5 1 0
  Depression 0 1 0 0 0 0 1 0
PAIN 8 7 3 0 11 11 2 0
  Abdominal pain NOS 3 5 1 0 1 4 1 0
  Penile pain 0 0 0 0 0 0 1 0
  Proctalgia 4 2 2 0 5 7 1 0
PULMONARY/UPPER RESPIRATORY 1 1 0 0 0 1 1 0
  Hiccups 0 1 0 0 0 1 1 0

Includes adverse events where relationship to protocol treatment is missing.

Adverse events were graded with CTCAE version 3.0.